Tipping Points in Refractive Cataract Surgery: Status Report on Presbyopia Correction Without Compromise
Supported by unrestricted educational grants from Abbott Medical Optics Inc. and Alcon Laboratories Inc.
Program Chair: Bonnie An Henderson, MD
Bonnie An Henderson, MD
Steven J. Dell, MD
Richard Tipperman, MD
John A. Vukich, MD
11:30 AM Registration/Lunch
12:00 PM Introduction Bonnie An Henderson, MD
12:08 PM Exploring Surgical Options for Presbyopia Correction Richard Tipperman, MD
12:18 PM Panel discussion
12:26 PM Understanding Visual Quality and Range of Vision Steven Dell, MD
12:36 PM Panel discussion
12:42 PM Addressing Residual Refractive Error John A. Vukich, MD
12:52 PM Panel discussion
1:00 PM Conclude
Ophthalmologists who attend this course will:
- Compare and contrast current treatment modalities for the surgical correction of presbyopia and identify appropriate treatment protocols to meet individual patient needs.
- Recognize the clinical impact of visual quality at various ranges of vision (near, intermediate, and distance), chromatic aberration and depth of focus, to improve proper lens selection and maximize the visual quality in today’s presbyopic patients.
- Accurately identify and define treatment parameters for residual refractive errors and implement treatment algorithms to address residual refractive errors after the surgical correction of presbyopia.
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the American Society of Cataract and Refractive Surgery (ASCRS) and EyeWorld news magazine. ASCRS is accredited by the ACCME to provide continuing medical education for physicians. ASCRS takes responsibility for the content, quality, and scientific integrity of this CME activity.
The American Society of Cataract and Refractive Surgery designates this live educational activity for a maximum of 1.0 AMA PRA Category 1 Credits™. Physicians should claim only credit commensurate with the extent of their participation in the activity.
All CME activities approved for AMA PRA Category 1 Credit™ are valid for recognition by the European Accreditation Council for Continuing Medical Education (EACCME). Physicians not licensed in the U.S. who participate in this CME activity are eligible for AMA PRA Category 1 Credit™.
Attendees registered as exhibitors, spouses, and guests are not eligible for CME credits.
Notice of Off-Label Use Presentations
This program may include presentations on drugs or devices or uses of drugs or devices that may not have been approved by the Food and Drug Administration (FDA) or have been approved by the FDA for specific uses only. The FDA has stated that it is the responsibility of the physician to determine the FDA clearance status of each drug or device he/she wishes to use in clinical practice. ASCRS is committed to the free exchange of medical education. Inclusion of any presentation in this program, including presentations of off-label uses, does not imply an endorsement by ASCRS of the uses, products, or techniques presented.
ASCRS fully complies with the legal requirements of the Americans with Disabilities Act (ADA) and the rules and regulations thereof. ASCRS also requires ADA compliance from its contracted vendors and facilities. Any participant in this educational program who requires special accommodation or services should contact an ASCRS or EyeWorld staff member onsite.